Direct detection of Mycobacterium tuberculosis complex in clinical samples by a molecular method based on GenoQuick technology
- PMID: 22422848
- PMCID: PMC3372117
- DOI: 10.1128/JCM.00567-12
Direct detection of Mycobacterium tuberculosis complex in clinical samples by a molecular method based on GenoQuick technology
Abstract
Several molecular systems for direct detection of Mycobacterium tuberculosis complex (MTBC) have recently been developed. The GenoQuick MTB assay (GQ-MTB) used in this study detected 82 of the 96 (85.4%) samples with MTBC, including 50 of 64 (78.1%) samples with negative acid-fast bacillus smears. Fifteen samples containing nontuberculous mycobacteria were also studied: 13 were GQ-MTB negative, one was positive, and one was indeterminate. GQ-MTB showed good effectiveness for the direct detection of MTBC from clinical samples.
Figures
References
-
- Behr MA, et al. 1999. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353:444–449 - PubMed
-
- Bhanu NV, van Soolingen D, van Embden JD, Seth P. 2004. Two Mycobacterium fortuitum strains isolated from pulmonary tuberculosis patients in Delhi harbour IS6110 homologue. Diagn. Microbiol. Infect. Dis. 48:107–110 - PubMed
-
- Centers for Disease Control and Prevention 2009. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb. Mortal. Wkly. Rep. 58:7–10 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
